<DOC>
	<DOCNO>NCT01031992</DOCNO>
	<brief_summary>Hereditary hemorrhagic telangiectasia ( HHT , Rendu-Osler-Weber Syndrome ) associate frequent nosebleed majority case . Several report literature support use antifibrinolytics like Tranexamic acid reduce nosebleed . The objective study test Tranexamic acid take orally 1. improve anemia ( lead increase hemoglobin level ) 2. reduce nosebleed .</brief_summary>
	<brief_title>Tranexamic Acid Epistaxis Hereditary Hemorrhagic Telangiectasia ( HHT )</brief_title>
	<detailed_description />
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Telangiectasia , Hereditary Hemorrhagic</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>hereditary hemorrhagic telangiectasia nosebleed desire treat . pregnant , minor , increased risk thrombotic event ( history sign cerebrovascular event , cardiac arrhythmia , biochemically increase coagulation parameter ) , renal insufficiency , history massive hematuria defect color vision .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Hereditary hemorrhagic telangiectasia</keyword>
	<keyword>Rendu-Osler-Weber syndrome</keyword>
	<keyword>Epistaxis</keyword>
	<keyword>Nosebleeds</keyword>
	<keyword>Anemia</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>Antifibrinolytics</keyword>
</DOC>